Event Date/Time: Jun 24, 2012 End Date/Time: Jul 01, 2012
Report as Spam

Description

14AMA PRA Category 1 Creditsâ„¢
14 Contact Hours
14 AAFP Prescribed Credits
Course Fee
Physicians $695
All Others - Course Fee$450
Plus the cost of the cruise

Target Audience
Pediatricians, Endocrinologists, Physicians, Diabetes Specialists, Physician Assistants, Nurse Practitioners, Nurses


Program Purpose / Objectives


1.PONDER: Getting off to a good start: initial care of any patient with diabetes.
•Describe how to foster an attitude of empowerment and realistic expectations in a patient or family of a child with newly diagnosed diabetes
•List at least 4 essential clinical tasks to accomplish with a newly diagnosed diabetes patient
•Identify four common health care provider behaviors that discourage patient adherence with diabetes self-care
2.SCHREINER: Beyond insulin and glucagon for persons with type 1 diabetes
•Describe the role of amylin in the pathophysiology of type 1 diabetes
•Identify the options for addressing amylin deficiency.
•Discuss the clinical aspects and patient education implications of using pramlintide.
3.ANDERSON: How to recognize and manage patient related stressors as barriers to diabetes self-care
•What is stress? And where is it located?
•What is ‘patient empowerment’ and how does it work in the relationship between the diabetes clinician and the patient with diabetes?
•How can diabetes clinicians assist patients in identify both ‘sticking points’ in diabetes self-care as well as ‘coping strategies’.
4.SCHREINER: The Ominous Octet as the type 2 diabetes "Rosetta Stone"
•Outline the eight defects contributing to type 2 diabetes.
•Consider the clinical tools for differentiating the ominous octet.
•Discuss strategies to treat the eight physiologic challenges of type 2 diabetes.
5.PONDER/ANDERSON: What clinicians can learn from ‘motivational interviewing’ to help persons with diabetes improve their self-care.
•Identify 2 ways in which ‘motivational interviewing’ differs from traditional methods of counseling or therapy.
•Define “rolling with resistance”.
6.SCHREINER: What’s new in the pharmaceutical pipeline for treating type 2 diabetes?
•Discuss the road from idea to FDA approval for new drugs.
•Describe the latest drug therapies under FDA review to treat diabetes.
•Review recent FDA warnings and cautions for currently approved diabetes drugs.
7.PONDER: Identifying and managing diabetes co-morbidities and early long term complications
•List three common co-morbid conditions in newly diagnosed patients with diabetes
•Discuss current strategies for screening and evaluation for common long term diabetes complications and their initial medical management
8.ANDERSON: Recognizing and managing depression in persons with diabetes
•Differentiate major depression from ‘diabetes burnout’
•Identify 2 treatment modalities that have proven to be helpful in treating depression in persons with diabetes.
•List 2 physical symptoms and 2 mental symptoms of clinical depression.
9.PONDER: Are “smart” insulin pumps a panacea for poor metabolic control in diabetes?
•Discuss the indications and contraindications for use of the insulin pump
•Describe the common features of modern insulin pumps and how they can improve glycemic control if properly applied
10.ANDERSON: How to optimize family support for persons with diabetes
•Describe the “helping dilemma” in families with a member with diabetes.
•Identify 2 primary examples of ‘unrealistic expectations’ family members sometimes have about diabetes management.
•Explain how the cycle of ‘miscarried helping’ begins in families living with diabetes.
11.PONDER: Peering into the flux: who is real time continuous glucose monitoring really for?
•Discuss the indication for use of real-time continuous glucose monitoring
•Describe the limitations of current RT-CGMS devices
•Interpret a basic RT-CGMS trend line
12.PONDER: Managing common insulin pump problems and how to remedy them
•List the 5 basic programmable features of a modern insulin pump device
•Describe how basic pump settings are generated and when to make adjustments in them
•List at least 3 common insulin pumping errors or misuse and how to identify them
13.SCHREINER: How to create a diabetes team in a primary care setting
•Use the chronic care model as a tool for building a diabetes team.
•Discuss how to access diabetes education services for patients in a primary care practice.
•Describe how to be reimbursed for diabetes education services.
14.SCHREINER: From stem cells to the artificial pancreas: Hot topics in Diabetes Research 2012
•Describe the path to a cure for diabetes.
•Discuss current clinical research strategies to augment beta cell activity.
•Identify the diabetes research agendas for key funding agencies.

Conference Sessions generally take place during the days at sea (as cruise itinerary allows) to avoid conflicts with Ports of Call or evening entertainment.

Venue

Cruising the Eastern Caribbean
Florida
United States
MORE INFO ON THIS VENUE